These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 11692445)

  • 1. The house is burning: an HIV clinician's view after 20 years.
    Follansbee S
    Focus; 2001 Aug; 16(9):1-5. PubMed ID: 11692445
    [No Abstract]   [Full Text] [Related]  

  • 2. How infrequent are opportunistic diseases and immune reconstitution syndromes among HIV-infected individuals who have favorable CD4+ cell count responses to antiretroviral therapy?
    Phillips P
    Clin Infect Dis; 2005 May; 40(9):1379-80; author reply 1380-1. PubMed ID: 15825049
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-HIV agents. Infections after HAART--who is at risk?
    TreatmentUpdate; 2000 Mar; 12(2):4-5. PubMed ID: 12125619
    [No Abstract]   [Full Text] [Related]  

  • 4. A clinician's perspective: when to start antiretroviral treatment and when to change therapy.
    Montaner JS; Lange JM
    J Biol Regul Homeost Agents; 1995; 9(3):114-8. PubMed ID: 8782020
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytomegalovirus disease in HIV infection: twenty years of a regional population's experience.
    Kim S; Snider JJ; Gill MJ
    Clin Infect Dis; 2006 Jun; 42(12):1808-9. PubMed ID: 16705594
    [No Abstract]   [Full Text] [Related]  

  • 6. Current status of HIV infection: a review for non-HIV-treating physicians.
    Knoll B; Lassmann B; Temesgen Z
    Int J Dermatol; 2007 Dec; 46(12):1219-28. PubMed ID: 18173512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune reconstitution in several forms.
    Ball SC
    AIDS Read; 2005 Jan; 15(1):17-20. PubMed ID: 15685730
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience and choice of drug therapy for human immunodeficiency virus disease.
    Brosgart CL; Mitchell TF; Coleman RL; Dyner T; Stephenson KE; Abrams DI
    Clin Infect Dis; 1999 Jan; 28(1):14-22. PubMed ID: 10028063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of physician agreement with recommended therapeutic guidelines for the management of HIV-associated disease.
    Montaner JS; Hogg RS; Heath KV; Phillips P; Craib KJ; Schechter MT; O'Shaughnessy MV
    Antivir Ther; 1996 Aug; 1(3):157-66. PubMed ID: 11322249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To start or not to start?
    Learned J
    Posit Aware; 2001; 12(5):28-9. PubMed ID: 11688482
    [No Abstract]   [Full Text] [Related]  

  • 11. Adherence to clinical guidelines for the therapeutic management of HIV disease.
    Heath KV; Hogg RS; Singer J; Schechter MT; O'Shaughnessy MV; Montaner JS
    Clin Invest Med; 1997 Dec; 20(6):381-7. PubMed ID: 9413635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of symptomatic human immunodeficiency virus-related lymphoid interstitial pneumonia in patients receiving highly active antiretroviral therapy.
    Dufour V; Wislez M; Bergot E; Mayaud C; Cadranel J
    Clin Infect Dis; 2003 May; 36(10):e127-30. PubMed ID: 12746792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study.
    Vibhagool A; Sungkanuparph S; Mootsikapun P; Chetchotisakd P; Tansuphaswaswadikul S; Bowonwatanuwong C; Ingsathit A
    Clin Infect Dis; 2003 May; 36(10):1329-31. PubMed ID: 12746781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New antiretroviral treatment guidelines from the IAS-USA panel.
    Labarga P; Blanco F
    AIDS Rev; 2012; 14(4):290. PubMed ID: 23390673
    [No Abstract]   [Full Text] [Related]  

  • 15. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment Issues' second survey of physicians' treatment practice.
    GMHC Treat Issues; 1997-1998 Winter; 12(1):3-17. PubMed ID: 11364988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HIV agents. Once-daily anti-HIV therapy in people co-infected with TB.
    TreatmentUpdate; 2004; 16(3):4-5. PubMed ID: 17219607
    [No Abstract]   [Full Text] [Related]  

  • 18. Update from CROI 2008 on HIV-related infections and conditions.
    McCord A
    Proj Inf Perspect; 2008 Apr; (45):17-24. PubMed ID: 19248294
    [No Abstract]   [Full Text] [Related]  

  • 19. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
    Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
    AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.